Aptevo Therapeutics (APVO) Tops Q1 EPS by 161c

Aptevo Therapeutics (NASDAQ: APVO) reported Q1 EPS of $0.26, $1.61 better than the analyst estimate of ($1.35).

For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Aptevo Therapeutics raises $4.5M through warrant exercise and PIPE